DPI, Amethis acquire minority stake in Egypt’s Marcyrl
Updated 4/4/2023 10:24:00 AM
Arab Finance: UK-based Development Partners International (DPI) and France-based investment fund manager Amethis have acquired a significant minority stake in Egyptian pharmaceutical company Marcyrl Pharmaceutical Industries, the three firms announced in a joint statement issued on April 4rd.
The investment, which has not been disclosed yet, will enable Marcyrl to further develop its technologies and expand its business across Africa.
“At Marcyrl, we are working to transform the way specialty treatments are made accessible across Egypt and the entire African continent, ensuring that specialty care treatments are available to those that need them the most,” Farid Habib Salib, Chairman of Marcyrl, said.
Marcyrl was founded in 1998 and has since grown to become one of the top 10 pharmaceutical companies in Egypt. The pharmaceutical firm focuses on the production of specialized medicines, and has launched novel antiviral and hormonal therapies to the local market.
Related News
